Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer

08/08/2018
/ Publications
/
Toxicity

A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...

Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer

08/02/2018
/ Publications
/
Hypofractionation
Quality of life

A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...

Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

08/09/2018
/ Publications
/
Quality of life

A study by the Seattle group analyzed 231 patients of localized prostate cancer treated with protons. Median follow-up was 1.7 years. Grade 3 toxicity was seen...

Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.

08/07/2018
/ Publications
/
Toxicity

A retrospective analysis on 100 patients' acute and late genitourinary (GU) and gastrointestinal (GI) toxicities associated with post-prostatectomy proton...

Cost effectiveness of prostate cancer radiotherapy.

08/06/2018
/ Publications
/
IMRT
Hypofractionation

This review article by Konski A, examined the data of cost-effectiveness analyses of various radiotherapy modalities including 3DCRT, IMRT, hypofractionated RT...

Finding Value for Protons: The Case of Prostate Cancer?

05/04/2018
/ Publications
/
Dosimetry
Quality of life

A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...

Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.

11/10/2017
/ Publications
/
Toxicity

This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.

The study demonstrated PBT...

Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.

11/11/2017
/ Publications
/
Hypofractionation

A study reported toxicity of 526 localized prostate cancer patients treated with proton therapy and demonstrated the safety of HFPT for localized PCa patients...

Establishing evidence-based indications for proton therapy.

10/11/2016
/ Publications
/
Clinical Trial
PT101

An overview of current clinical trials of proton therapy published in the Red Journal. A total 122 ongoing trials with target enrolment of over 42,000 patients...

Biochemical Results, Toxicity, Patient QoL After Delivery of Dose-Escalated Image Guided PT for Prostate Cancer

01/02/2016
/ Publications
/
Toxicity

A large series of 1327 localized prostate cancer patients reported 5-year biochemical control rate, toxicity and patient-reported quality of life after proton...